Official Symbol

CETPprovided by HGNC

Official Full Name

cholesteryl ester transfer protein, plasmaprovided by HGNC

Primary source

HGNC:1869

See related

Ensembl:ENSG00000087237; HPRD:00325; MIM:118470

Gene type

protein coding

RefSeq status

REVIEWED

Organism

Homo sapiens

Lineage

Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo

Also known as

HDLCQ10; CETP

Summary

Cholesteryl ester transfer protein (CETP) transfers cholesteryl esters between lipoproteins. CETP may effect susceptibility to atherosclerosis. [provided by RefSeq]

Go to reference sequence detailsTry our new Sequence Viewer

chromosome: 16; Location: 16q21See CETP in MapViewer

Related Articles in PubMed

GeneRIFs: Gene References Into FunctionWhat's a GeneRIF?

	1.	Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
	2.	Bexarotene increased VLDL-associated TG in both E3L (+47%) and E3L.CETP (+29%) mice by increasing VLDL-TG production (+68%).
	3.	Our results suggest that CETP gene polymorphisms might influence white matter lesion load and the risk of vascular dementia, the latter in non-carriers of the APOE4 allele.
	4.	The study did not confirm associations between genetic polymorphisms of ABCA1 transporter, CETP and apoE and abnormal serum lipid profile during remission of nephrotic syndrome.
	5.	The Taq1B CETP gene polymorphism should be a strong determinant of HDL-C in hyperlipidemia patients, and might contribute to the heterogeneity in HDL-C response to dietary intervention.
	6.	The risk in non hypertensive and male coronary heart disease patients is higher in the presence of CETP B1B1 and CA genotypes.
	7.	CETP, but not hepatic lipase or lipoprotein lipase, has a role in regulating HDL-c and LDL-c levels in menopausal women
	8.	Early-life sodium exposure exacerbated hypertension and unmasked stroke susceptibility, with greater female vulnerability in hypertensive, hyperlipidemic transgenic CETP rats
	9.	analysis of Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis
	10.	probucol decreases plasma ANGPTL3 and HDL phospholipids while increasing prebeta1-HDL and cholesteryl ester transfer protein
	11.	The level of CETP expression can influence the responsiveness to dietary fat and may lead to fat intolerance.
	12.	Results indicate that I405V polymorphism of the cholesteryl ester transfer protein may affect the HDL cholesterol levels in the Turkish population.
	13.	No association was found between the L296Q polymorphism in the CETP gene and T2DM as well as plasma lipid levels in various groups of Chinese in this study.
	14.	study of the influence of ATP-binding cassette A1 and CETP genetic variants on lipoprotein subclasses demonstrates the importance of interpreting lipoprotein subclasses within the context of the biochemical processes
	15.	The allelic frequencies of B2 and B1 allele of CETP was 41.0% and 59.0% and the genetic polymorphisms of ABCA1 in Chinese Han ethnic population are significantly different from Caucasians residing in USA or Europe.
	16.	These results suggest that CETP TaqIB (B2 allele as protective factor) genetic polymorphisms may be associated with the non-valvular atrial fibrillation in the Chinese Han population.
	17.	The CETP-TaqIB genotype is independently associated with insulin resistance and lipid metabolism. It may be an important risk factor of insulin resistance in type 2 diabetes.
	18.	Polymorphisms may increase risk of myocardial infarct.
	19.	Data suggests that the B2 allele is associated with higher concentrations of HDL-C, which confer a protective effect with regard to coronary atherosclerosis.
	20.	Although CETP activity correlated with HDL-C levels, neither high CETP activity nor low HDL-C was associated with cardiovascular events in chronic kidney disease stage V patients.
	21.	an association between apo E polymorphism and CETP activity and this association did not affect the relationship between apo E polymorphism and triglyceride and HDL cholesterol concentrations.
	22.	Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathway.
	23.	CETP TaqIB polymorphism appears not to be associated with the likelihood of metabolic syndrome other than atherogenic dyslipidemia in adult Turkish population.
	24.	CETP may nt be strongly associated with increased HDL-cholesterol
	25.	Mineralocorticoid and blood pressure responsiveness to dietary salt intake are not significantly related to physiological interindividual differences in plasma CETP.
	26.	Taq 1B polymorphism of cholesteryl ester transfer protein gene was associated with changes in lipids profile and plasma cholesteryl ester transfer protein activity in the selected population
	27.	The Int 14A variant of the CETP gene may increase odds for healthy aging.
	28.	In statin-treated male CAD patients, genetic variation conferring low CETP levels is associated with increased 10-year mortality.
	29.	CETP gene variations influence cerebral and peripheral cholesterol metabolism, but not Alzheimer's disease risk
	30.	FXRalpha down-regulates CETP gene expression via binding to the DR4RE sequence within the CETP 5' promoter and this FXRalpha binding is essential for FXRalpha inhibition of LXRalpha-induced CETP expression.
	31.	simultaneous presence of CETP (Cholesteryl ester transfer protein)and LIPC (hepatic lipase) gene variants yield low CETP mass and HL activity and high plasma HDL-cholesterol ; an increased risk for coronary artery disease was found in these patients.
	32.	Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
	33.	Unlike men, women the age- and race-adjusted odds ratio was found to be significant in 4 out of the 5 CETP single variants in a case-control study from western Washington State.
	34.	CETP plays a complex role in modulating ER stress, with its expression inducing the response and its cholesteryl ester transfer activity and differential splicing modulating the response in other ways.
	35.	CETP Taq1B polymorphism showed no association with obesity in North Indian subjects.
	36.	The polymorphism predicted differences in HDL-C and ApoAI in the Hei Yi Zhuang but not in the Han Chinese, even after adjustment for confounding variables.
	37.	lipoprotein composition may influence the status of lipid transfer inhibitor protein activity
	38.	Report the effect of CETP overexpression and inhibition on reverse cholesterol transport.
	39.	The association of alcohol with HDL-C levels was modified by CETP TaqIB2 carrier status, and there was also a suggestion of a gene-environment interaction on the risk of CHD.
	40.	study suggests that, despite a relationship between a common CETP gene variation and plasma cholesteryl ester transfer, the association between CETP gene and HDL cholesterol appears to be in part unexplained by plasma cholesteryl ester transfer process
	41.	Tha plasma concentration of HDL cholesterol is influenced by the TaqIB CETP polymorphism, but inconsistent associations of this CETP gene variant with cardiovascular disease have been reported [review]
	42.	The A-allele of the CEPT gene C629A SNP int the promoter region was associated with decreased cardiovascular death.
	43.	genotype of gene LPL and B2 allele of gene CETP in patients elder 90 years are found significantly more frequently than in younger patients, that makes possible to consider they as markers of favorable course of disease and patients' long life.
	44.	the role of natural variations in modulating CETP and high density lipoprotein-cholesterol (HDL-C) levels
	45.	Three CETP genotypes that are associated with moderate inhibition of CETP activity (and, therefore, modestly higher HDL-C levels) show weakly inverse associations with coronary risk.
	46.	CETP plays an important role in the metabolic syndrome, possibly involving novel functions of CETP
	47.	Inhibition of CETP reduced the VLDL apoE pool size (-28%) by increasing the VLDL apoE fractional catabolic rate (77%) and leaving the VLDL apoE production rate unchanged
	48.	CETP has a novel protective role in early steps of reverse cholesterol transport via its complexation with high-density lipoprotein (HDL) particles.
	49.	Multiple linear regression analysis confirmed the independent association of cellular cholesterol efflux to plasma with CETP genotype
	50.	TaqIB polymorphism is associated with plasma HDL cholesterol levels and parental history of cardiovascular disease in Taiwan.
	51.	CETP overexpression in transgenic mice does not affect reverse cholesterol transport from macrophages to feces in vivo or the protection conferred by HDL against LDL oxidative modification
	52.	The G allele of CETP D442G may have a potential protective effect against the development of AD, especially in APOE epsilon4 carriers, in Northern Han-Chinese, possibly through regulating the HDL level in the brain.
	53.	Clinical trial of gene-disease association. (HuGE Navigator)
	54.	Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)
	55.	Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)
	56.	Clinical trial of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)
	57.	Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)
	58.	Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)
	59.	Observational study of gene-environment interaction. (HuGE Navigator)
	60.	Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
	61.	Meta-analysis of gene-disease association. (HuGE Navigator)
	62.	Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)
	63.	Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)
	64.	Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
	65.	Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)
	66.	Observational study of genotype prevalence. (HuGE Navigator)
	67.	Observational study of gene-disease association. (HuGE Navigator)
	68.	CT heterozygotes ( cholesteryl ester transfer protein variants C>T/In9 ) gained more weight with overfeeding and had higher fat mass (FM) than the CC homozygotes
	69.	Highlight a previously unknown positive relationship between CETP plasma levels and blood coagulability that might relate to risks for thrombotic events.
	70.	the V/V genotype of the I405V CETP polymorphism is more frequent among very old people than young ones, and is associated with a lower incidence of vascular damage
	71.	TaqIB polymorphism in CETP gene results in a significant increase in the risk of early onset myocardial infarction in smokers who carry the TAQIB allele.
	72.	Carriers of polymorphism of the CETP gene increases the risk of Alzheimer disease in the abscence of the apolipoprotein e-4 allels.
	73.	the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus may affect postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia
	74.	plasma HDL-Cholesterol levels differ according to Cholesterol Ester Transfer protein (CETP) genotypes and was not affected by dietary fat intake
	75.	interaction between the CETP TaqIB polymorphism and intake of dietary fat on plasma HDL concentration.
	76.	the CETP TaqIB polymorphism is a good genetic predictor of cardiac mortality in type 2 diabetes.
	77.	High CETP promotes the transport of lipids among lipoproteins, which changed the lipid composition of LDL, resulting in the increase of in vivo Ox-LDL level, and subsequently contributing to the atherogenic process in dyslipidaemias subjects.
	78.	CETP and APOE genotypes account for up to 9% of the variance in HDL-c phenotypes in the HERITAGE Family Study
	79.	The VV genotype tended to be associated with lower risk of CHD mortality in women, but this difference was not statistically significant.
	80.	The results demonstrate that the decreased serum albumin level might be a main determinant of the increased CETP concentration in pediatric nephrotic syndrome.
	81.	Studies in adipocytic cells strongly support a novel role for CETP in intracellular lipid transport and storage.
	82.	there is the possibility that the CETP gene variation may affect coronary risk apart from the level of HDL-C
	83.	interaction of this LIPC variant with CETP on HDL-cholesterol levels affecting risk of myocardial infarct in men
	84.	CETP polymorphism were associated with moderately increased LDL peak aprticle size.
	85.	Genetic variation in the CETP gene is associated with protective HDL-cholestrol levels.
	86.	A significant sex specific effect of the TaqIB CETP polymorphism on insulin resistance parameters HDL-cholesterol and sdLDL is found in an Austrian population based study.
	87.	Genetic variations at the CETP gene locus may account for a significant proportion of HDLC variation in Vietnamese children.
	88.	Cholesteryl ester transfer protein, plasma (CETP) Taq1B gene polymorphism is an association with low HDL cholesterol levels in patients with type II diabetes mellitus and healthy controls.
	89.	I405V polymorphism may have potential importance in screening individuals at high risk for developing coronary stenosis.
	90.	Bone marrow-derived CETP from CETP transgenic mice induces a proatherogenic lipoprotein profile and promotes the development of atherosclerotic lesions in LDL receptor knockout mice.
	91.	Among these genetic polymorphisms, TaqIB of CETP and MspI of apolipoprotein AI appeared to help significantly to identify diabetic individuals. In particular, the former may have an additional role in the primary prevention of coronary disease.
	92.	CETP genotypes have effects on the serum lipid profile among renal transplant patients.
	93.	Increased fasting CETP activity may contribute to increased risk of atherosclerosis in subjects with impaired glucose tolerance
	94.	Multivariate analysis showed the common AAB2 haplotype defined by the G-2708A, C-629A and TaqIB polymorphisms, was consistently associated with reduced CETP activity and increased HDL-C levels
	95.	Reviewed studies reveal that human subjects with heterozygous CETP deficiency and an HDL cholesterol level >60 mg/dL have a reduced risk of coronary heart disease.
	96.	Men with a CETP mutation had the lowest rates of coronary heart disease; whether a CETP mutation offers additional protection against CHD warrants further investigation.
	97.	The molecular mechanism of the apoCI-mediated blockade of CETP activity is reported.
	98.	CEPT gene locus have an additional and interactive influence on plasma lipid and lipoprotein levels in children.
	99.	data collected in a cohort of 779 patients of whom 342 had developed restenosis indicate that the common variants for CETP and PON are not associated with incidence of restenosis after PTCA
	100.	This study suggest that CETP behaves as a modifier gene of the AD risk associated with the APOE epsilon4 allele, possibly through modulation of brain cholesterol metabolism
	101.	CETP mass was higher in men with metabolic syndrome but not in women.
	102.	demonstrate a critical role of CETP in nicotinic acid-mediated HDL elevation
	103.	D442G mutation is common in Korean postmenopausal women and it is associated with increased plasma HDL cholesterol level.
	104.	Human cholestryl ester transfer protein polymorphism is associated with cardiovascular diseases
	105.	CETP genotype may contribute to the interindividual differences in plasma HDL-C subfraction changes occurring with endurance exercise training in sedentary middle- to older-aged men and women
	106.	Postprandial chylomicrons may play an important role in promoting reverse cholesterol transport in vivo by serving as the preferred ultimate vehicle for transporting cholesterol released from cell membranes to the liver via LCAT and CETP.
	107.	CETP genotype did not influence lipid and lipoprotein levels in pregnant women.
	108.	In patients with CAD, the CETP/-629A allele had a strong protective effect on future mortality from cardiovascular causes, independent of its role on HDL cholesterol and CETP activity levels.
	109.	CETP is increased and associated with the atherogenic lipoprotein profile in obese children
	110.	CETP Taq1B showed significant association with changes in plasma lipid and lipoproteins for patients in cardiac rehabilitation
	111.	the rare allele of the cholesterol ester transfer protein (CETP) TaqIB variant was associated with lower ICA IMT in men.
	112.	Role of CETP in modulating HDL-C and cardiovascular disease.
	113.	The expression of human CETP in db/db mice prevented the formation of diet-induced lesions, suggesting an antiatherogenic effect of CETP in the context of diabetic obesity.
	114.	Sp1 and Sp3 regulate human CETP promoter activity through three Sp1/Sp3 binding sites in a distinct manner
	115.	negative charge of LDL surface lipids, but not protein, is an important regulator of CETP and LTIP activity
	116.	An association between the CETP TaqIB polymorphism and atrial fibrillation.
	117.	There were, however, no significant associations of CETP genotype with either childhood IQ or current cognitive function in old age, or with lifetime change in cognitive function.
	118.	multiple, less common SNPs and haplotype variants underlie CETP-related coronary artery disease risk; occurrence of risk-related variants on separate haplotypes suggests genetic-risk complexity and allelic heterogeneity
	119.	CETP localizes B cells in germinal centres, a proportion of post-germinal centre B cells and their neoplastic counterparts.
	120.	present observations provide direct support for a potent specific inhibition of CETP by plasma apoCI in vivo
	121.	The activity and mass of cholesteryl ester transfer protein (CETP) in cord blood were higher than those in adult blood.
	122.	No statistically significant differences have emerged with respect to either genotype or allele frequencies between late onset Alzheimer's disease and control populations when examining CETP TaqI B polymorphism.
	123.	The TT genotype of HL mutation may serve as a protective factor against vascular disease by increasing HDL cholesterol levels in hemodialysis patients with higher CETP levels.
	124.	genetic variation at the CETP gene locus may account for a significant proportion of the difference in HDL-C levels
	125.	Role of CETP in modulating HDL-C and cardiovascular disease.
	126.	CETP expression in APOE*3-Leiden (E3L) mice shifts the distribution of cholesterol from HDL to VLDL/LDL, reduces plasma-mediated SR-BI-dependent cholesterol efflux, and represents a clear pro-atherogenic factor in E3L mice.
	127.	CETP gene may play an important role in determining coronary artery disease in Corsican population
	128.	Provides additional evidence for the association of CETP with high density lipoprotein levels and suggests that CETP is an atherogenic protein increasing the risk of myocardial infarction.
	129.	induction of CETP constitutes a major determinant of the effect of LXR agonists on cholesterol transport and excretion
	130.	CETP gene mutation (D442G) increases low-density lipoprotein particle size in patients with coronary heart disease.
	131.	Our data are in favour of an association between CETP and developing coronary artery disease (CAD), as well as the extent of CAD.
	132.	CETP mediates selective uptake of HDL-cholesteryl ester by hepatocytes
	133.	Results showed a gene-gene interaction between the CETP and the ApoE loci in determining HDL-C concentrations.
	134.	Association between HDL-cholesterol and the Taq1B polymorphism in the cholesterol ester transfer protein gene in obese women.
	135.	A novel mutation in the intron 1 splice donor site of the cholesterol ester transfer protein (CETP) gene as a cause of hyperalphalipoproteinemia.
	136.	CETP is modified by LTIP and has a role in remodeling of HDL3 and HDL2 particles in subclass-specific ways, strongly implicating it as a regulator of HDL metabolism
	137.	overexpression of apoCI does not represent a suitable method for decreasing total CE transfer activity in CETPTg/apoCITg mice, owing to an hyperlipidaemia-mediated effect on CETP gene expression
	138.	CETP has independent effects on lipid changes following fluvastatin treatment.
	139.	the association between high (HDL) and low-density (LDL) cholesterol concentrations and family-derived haplotypes based on six common SNPs in the cholesteryl-ester transfer protein (CETP) gene
	140.	In I405V CETP polymorphism, percentage reductions in plasma total cholesterol with consumption of plant sterol ester were not significant. CETP concentration diminished only in the II phenotype.
	141.	Data describe a variable length tandem repeat in the cholesteryl ester transfer protein promoter that is highly polymorphic with respect to both length and sequence; the short allele of this repeat is associated with high HDL cholesterol levels in vivo.
	142.	Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay.
	143.	Association of exceptional longevity with homozygosity for the valine 405 allele of CETP may explain in part the link between lipoprotein particle size and exceptional longevity
	144.	B2 allele of the TaqIB polymorphism is less frequent in African Americans compared with Caucasians;this polymorphism is unlikely to contribute to higher levels of HDL-C reported in African Americans.
	145.	Significant association between CETP genotypes or haplotypes and late onset AD was not detected in these two study cohorts.
	146.	IVS14A and 451Q mutants of cholesteryl ester transfer protein (CETP) gene were rare in Chinese population and 442G mutant gene was possibly one of the susceptibility factors to Coronary Arteriosclerosis in Chinese.
	147.	The CETP polymorphism is a significant predictor of future cardiovascular disease events in statin-treated patients with familial hypercholesterolemia
	148.	Cholestery ester transfer protein (CETP) transfers cholesteryl esters between lipoproteins. CETP may effect susceptibility to atherosclerosis.
	149.	a rationale to evaluate the effects of CETP inhibitor treatment on plasma cholesterol ester transfer and on cardiovascular risk in diabetes-associated hypertriglyceridemia.
	150.	Recombinant CETP expression in mouse increases direct removal of HDL CE in the liver and this process is independent of SR-BI, LRP, and possibly LDLR.
	151.	Role for CETP in remodeling HDL and providing an alternative pathway for the selective uptake of HDL cholesteryl ester by the liver.
	152.	phospholipid and cholesteryl ester transfer proteins are important in very low and high-density lipoprotein metabolism and display concerted actions in patients with type 2 diabetes [review]
	153.	elevated PLTP activity in human cholesteryl ester transfer protein (huCEPT) transgenic mice results in an increase in VLDL secretion
	154.	In men with coronary heart disease (CHD) and high density lipoprotein cholesterol (HDL-C)deficiency, the CETP TaqI B2B2 genotype is significantly reduced and is associated with higher levels of plasma HDL-C and lower CHD risk.
	155.	TaqIB2 allele was found not to be associated with significant changes in coronary artery disease risk
	156.	role in the regulation of the vascular cell functions
	157.	Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration.
	158.	These findings provide evidence of a protective effect of the B2B2 genotype of the CETP Taq1B polymorphism on the likelihood of having a first event of Acute Coronary Syndromes in normal-weight persons
	159.	attenuates atherosclerosis in ovariectomized mice [Cholesteryl ester transfer protein ]

Markers

Genotypes

See CETP Variation Viewer Report
See CETP SNP GeneView Report
See CETP SNP Genotype Report

Phenotypes

Pathways

GeneOntology Provided by GOA

Preferred Names

cholesteryl ester transfer protein, plasma

Names

cholesteryl ester transfer protein, plasma

lipid transfer protein

RefSeqs maintained independently of Annotated Genomes

These reference sequences exist independently of genome builds. Explain

These reference sequences are curated independently of the genome annotation cycle, so their versions may not match the RefSeq versions in the current genome build. Identify version mismatches by comparing the version of the RefSeq in this section to the one reported in Genomic regions, transcripts, and products above.

Genomic

1. NG_008952.1 RefSeqGene

   Range

   5001..26922

   Download

   GenBank  FASTA Sequence Viewer (Graphics)

mRNA and Protein(s)

1. NM_000078.2→NP_000069.2 cholesteryl ester transfer protein, plasma precursor

   Source sequence(s)

   AA999853,M30185

   Consensus CDS

   CCDS10772.1

   UniProtKB/Swiss-Prot

   P11597

   Conserved Domains (2) summary

   cd00025
   Location:27–254
   Blast Score:516

   BPI1; BPI/LBP/CETP N-terminal domain; Bactericidal permeability-increasing protein (BPI) / Lipopolysaccharide-binding protein (LBP) / Cholesteryl ester transfer protein (CETP) N-terminal domain; binds to and neutralizes lipopolysaccharides from the outer...

   cl00188
   Location:277–479
   Blast Score:267

   BPI; BPI/LBP/CETP domain; Bactericidal permeability-increasing protein (BPI) / Lipopolysaccharide-binding protein (LBP) / Cholesteryl ester transfer protein (CETP) domain; binds to and neutralizes lipopolysaccharides from the outer membrane of Gram-negative...

RefSeqs of Annotated Genomes: Build 37.1

The following sections contain reference sequences that belong to a specific genome build. Explain

This section includes genomic Reference Sequences (RefSeqs) from all assemblies on which this gene is annotated, such as RefSeqs for chromosomes and scaffolds (contigs) from both reference and alternate assemblies. Model RNAs and proteins are also reported here.

Genome Reference Consortium Human Build 37 (GRCh37), Primary_Assembly

Genomic

1. NC_000016.9 Genome Reference Consortium Human Build 37 (GRCh37), Primary_Assembly

   Range

   56995835..57017756

   Download

   GenBank  FASTA Sequence Viewer (Graphics)

2. NT_010498.15

   Range

   10610034..10631955

   Download

   GenBank  FASTA Sequence Viewer (Graphics)

Alternate assembly (Celera)

Genomic

1. AC_000059.1 Alternate assembly (Celera)

   Range

   41496117..41518031

   Download

   GenBank  FASTA Sequence Viewer (Graphics)

2. NW_926462.1

   Range

   10560916..10582830

   Download

   GenBank  FASTA Sequence Viewer (Graphics)

Alternate assembly (HuRef)

Genomic

1. AC_000148.1 Alternate assembly (HuRef)

   Range

   42865207..42887119

   Download

   GenBank  FASTA Sequence Viewer (Graphics)

2. NW_001838290.1

   Range

   1152112..1174024

   Download

   GenBank  FASTA Sequence Viewer (Graphics)

• MIM 118470
• PharmGKB PA108
• GeneTests for MIM: 118470
• HPRD 00325
• UCSC UCSC
• UniGene Hs.89538